Codexis to Participate in Upcoming Virtual Healthcare Conferences

Rhea-AI Summary

Codexis (Nasdaq: CDXS) announced participation in three upcoming virtual investment conferences on November 16-18, 2021, showcasing its leading enzyme engineering capabilities. The events include the 12th Annual Craig-Hallum Alpha Select Conference, the Stifel 2021 Virtual Healthcare Conference, and the Jefferies London Healthcare Conference with scheduled 1x1 meetings and fireside chats. Webcasts will be available on Codexis' Investor Relations webpage for 30 days post-event. Codexis' innovations in enzyme technology aim to enhance sustainable manufacturing and biotherapeutics.

REDWOOD CITY, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that management will participate in three upcoming virtual investment conferences.

The 12^th Annual Craig-Hallum Alpha Select Conference — November 16, 2021, management will attend and host 1x1 investor meetings

The Stifel 2021 Virtual Healthcare Conference — November 17, 2021 at 2:40 p.m. ET, fireside chat

The Jefferies London Healthcare Conference — November 18, 2021 at 3:00 a.m. ET, on-demand fireside chat

Webcasts of the Stifel and Jefferies presentations will be available in the Investor Relations section of the Company’s website, http://ir.codexis.com. Replays of the webcasts will be archived for 30 days following their respective presentation dates.

About Codexis
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver^® platform to discover and develop novel, high performance enzymes and novel biotherapeutics. Codexis enzymes have applications in the sustainable manufacturing of pharmaceuticals, food, and industrial products; in the creation of the next generation of life science tools; and as gene therapy and biologic therapeutics. The Company’s unique performance enzymes drive improvements such as: reduced energy usage, waste generation and capital requirements; higher yields; higher fidelity diagnostics; and more efficacious therapeutics. Codexis enzymes enable the promise of synthetic biology to improve the health of people and the planet. For more information, visit www.codexis.com.

Investor Relations Contact:
Argot Partners
Stephanie Marks/Carrie McKim
(212) 600-1902
Codexis@argotpartners.com

FAQ

What is Codexis participating in on November 16, 2021?

Codexis will participate in the 12th Annual Craig-Hallum Alpha Select Conference, hosting 1x1 investor meetings.

What time is Codexis' fireside chat at the Stifel 2021 Virtual Healthcare Conference?

Codexis' fireside chat at the Stifel 2021 Virtual Healthcare Conference is scheduled for November 17, 2021, at 2:40 p.m. ET.

What is the date of the Jefferies London Healthcare Conference for Codexis?

Codexis will participate in the Jefferies London Healthcare Conference on November 18, 2021, at 3:00 a.m. ET.

Where can I find the webcasts of Codexis' presentations?

Webcasts of Codexis' presentations will be available in the Investor Relations section of their website and archived for 30 days after the events.

What is the focus of Codexis as an enzyme engineering company?

Codexis focuses on discovering and developing high-performance enzymes for sustainable manufacturing, pharmaceuticals, and biotherapeutics.